A recent study notes that contraceptives could help heal acne, or could make it worse—it all depends on which type is ingested.
Via its campaign Step Up For Vitiligo, the Vitiligo Working Group is working to bring global awareness to the autoimmune disease and support those who are affected by it.
A recent Mediaplanet media campaign encourages readers to protect their skin against the sun’s damaging rays and to educate themselves on the newest skin cancer technologies and treatments available.
As part of its 25th anniversary celebration, Cynosure Inc President Michael Davin and other members of the company’s management team will ring the NASDAQ Stock Market’s Closing Bell on Wednesday, July 27.
The recently founded North American Society for Hair Restoration (NASHR) strives to ensure that members receive the proper training on hair restoration procedures, and that they provide the best patient experience possible.
AXIM Biotechnologies Inc announces the launch of human dermatological clinical trials using AXIM’s patent-pending topical ointment formula AX-1602.
The first and only prognostic test for breast cancer is now available at Augusta University.
According to a recent assessment from the Agency for Healthcare Research and Quality, the rate of women undergoing mastectomies increased 36% between 2005 and 2013, and bilateral mastectomies more than tripled.
The appeal of medical tourism for cosmetic surgery paints a picture of cost-effective surgeries amid beautiful landscapes. Yet, warnings from the International Society of Hair Restoration Surgery (ISHRS) caution individuals may be buying unsafe, illegal procedures performed by technicians, not qualified physicians.
MiMedx Group, a leader in regenerative medicine using human amniotic tissue products and therapies, announces the publication of its most recent peer-reviewed independent clinical case series of MiMedx EpiFix allografts.
Allergan, parent company of Juvéderm Volbella XC, received FDA approval for the use of the product in perioral lines and for augmentation of the lips in adults age 21 and older.
A study led by Darrick E. Antell, MD, a Lenox Hill Hospital and New York City-based plastic surgeon, suggests that a full-incision surgical technique is preferable to a short-scar method in facelift patients.
For as many as 8 out of 10 preteens and adolescent teens, acne is a side effect of puberty. In an effort to safeguard skin health, Galderma Laboratories created an open-label, single-center study to evaluate an acne regimen comprised of Epiduo (adapalene/benzoyl peroxide) Gel 0.1%/2.5% and Cetaphil facial cleanser and SPF 30 sunscreen.
The study utilizing technology from Puregraft LLC, led by Professor Marcos Sforza (United Kingdom) and co-workers, used fat transfer to the breast to correct deformities and asymmetries following breast augmentation surgery.
Cynosure Inc announces the recent FDA clearance of its PicoSure energy delivery system for tattoos and pigmented lesions.
The creator of the Electronic Medical Assistant, a specialty-specific electronic health record for otolaryngology, dermatology, and plastic surgery, announced it won the No. 1 rank in Black Book Research in the dermatology, otolaryngology and plastic surgery categories.
ABRY Partners announces it has entered an agreement to acquire a majority interest in Oliver Street Dermatology Holdings LLC (dba Dermatology Associates).
Research and Markets releases a new report on the global facial aesthetics market.
Celebrations continue at Galderma Laboratories with the milestone of its new Research and Development center.
Staging systems like those used to classify cancerous tumors could assist in educating patients about the complexity of rhinoplasty and help manage outcome expectations.